Past research has shown that sexual-minority people have a heightened risk of CVD, especially when they also belong to other ...

The comparison exposes cracks in US healthcare, where the focus is more on treatment than prevention, says Rishi Wadhera.

Part of the benefit may be due to BP-lowering effects of the drug and/or fewer abnormal heart rhythms, says Seemant ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.